ICPT - Intercept Pharmaceuticals - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Intercept Pharmaceuticals's activity chart (see below) currently has 473 price targets and 408 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.37% with an average time for these price targets to be met of 77.95 days.

Most recent stock forecast was given by from CANACCORD on 27-Sep-2023. First documented stock forecast 13-Aug-2013.

Best performing analysts who are covering ICPT - Intercept Pharmaceuticals:

Alethia Young Brian Skorney Navin Jacob Ritu Baral Andrew Berens

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Edward Nash (CANACCORD)

Buy Since 03-Aug-2023

$19

$20

Please subscribe to see extended stock data

Mayank Mamtani (B. RILEY)

Buy Since 12-Jan-2022

$19

$15

Please subscribe to see extended stock data

Ed Arce (WESTPARK)

Buy Since 03-Aug-2023

$19

Please subscribe to see extended stock data

Brian Abrahams (RBC)

Hold Since 10-Nov-2020

$19

$13

Please subscribe to see extended stock data

Brian Skorney (BAIRD)

Buy Since 10-Nov-2020

$19

$18

Please subscribe to see extended stock data

Show more analysts

Load Price Targets and Ratings Chart

Please expand the browser size to see the chart

What is ICPT (Intercept Pharmaceuticals) average time for price targets to be met?

On average it took 77.95 days on average for the stock forecasts to be realized with a an average price target met ratio 31.37

Which analyst has the current highest performing score on ICPT (Intercept Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on ICPT (Intercept Pharmaceuticals)?

Alethia Young has 3 price targets and 3 ratings on ICPT

Which analyst is the currently most bullish on ICPT (Intercept Pharmaceuticals)?

Matthew Roden with highest potential upside - $446

Which analyst is the currently most reserved on ICPT (Intercept Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$7